A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir

ConclusionsThis study suggested CHB patients treated with TDF may experience increased risks of bone loss and renal deficits compared to those treated with ETV.
Source: Hepatology International - Category: Infectious Diseases Source Type: research